Results 261 to 270 of about 434,626 (386)

Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022-June 2023. [PDF]

J Viral Hepat
Mazzilli S, Aslam MK, Ahmed M, Wailly Y, Miazek M, Ashraf S, Ravji A, de Glanville WA, Isaakidis P.   +8 more
europepmc   +1 more source

Optimal Control Analysis of HCV Disease in a Community with Inflow of Infected Immigrants

, 2015
Neterindwa Ainea, Estomih S. Massawe, Oluwole Daniel Makinde, Lucy Namkinga   +3 more
openalex   +1 more source

Hepatitis C virus (HCV) core protein assay in chronic hemodialysis patients.

, 2001
Kent Doi, Tokuichiro Sugimoto, Masakazu Akashi, Tetsuhiro Tanaka, Hitoshi Tagawa, Kyosuke Nishio, Akiko Ogura, Richiko Sato, Tadahiro Nishi, Noriko Kimura   +9 more
openalex   +2 more sources

Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE) [PDF]

, 2011
Cláudia Goldenstein‐Schainberg, A. P. do Nascimento, André LS Hayata, Eloísa Bonfá   +3 more
openalex   +1 more source

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease

, 1998
M. Alter, H. Margolis
semanticscholar   +1 more source

Targeting SPP1‐CD44‐Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis

Cancer Science, EarlyView.
SPP1 was identified as a key driver of intratumoral fibrosis and hepatocellular carcinoma (HCC) progression through transcriptomic, histological, and functional analyses. Mechanistically, SPP1 promotes HSC activation and fibrosis via the SPP1–CD44–GLI1 axis, and pharmacologic inhibition of Hedgehog signaling effectively reduces tumor growth and ...
Atsushi Nara, Shu Shimada, Yoshimitsu Akiyama, Megumi Hatano, Yusuke Chino, Suguru Miyazawa, Hanako Tamura, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Shuichi Watanabe, Eriko Katsuta, Keiichi Akahoshi, Kenichi Ohashi, Minoru Tanabe, Daisuke Ban, Shinji Tanaka   +16 more
wiley   +1 more source

Association of IL28B Polymorphisms With Hepatitis C Susceptibility in Southern Iran's β-Thalassemia Population: A Cross-Sectional Study. [PDF]

Health Sci Rep
Askari F, Kargar M, Deris Zayeri Z, Jalalifar MA, Keikhaei B, Kaydani GA.   +5 more
europepmc   +1 more source

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

New England Journal of Medicine, 2014
P. Ferenci, D. Bernstein, J. Lalezari, D. Cohen, Yan Luo, C. Cooper, E. Tam, R. Marinho, N. Tsai, A. Nyberg, T. Box, Z. Younes, P. Enayati, Sinikka Green, Y. Baruch, B. Bhandari, F. Căruntu, T. Sepe, Vladimir P Chulanov, E. Janczewska, G. Rizzardini, J. Gervain, R. Planas, Christophe Moreno, T. Hassanein, W. Xie, M. King, T. Podsadecki, K. Reddy   +28 more
semanticscholar   +1 more source

Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

Cell Proliferation, EarlyView.
Mitochondrial quality control (MQC) impairment plays a central role in driving the pathogenesis of metabolism‐associated steatotic liver disease (MASLD). Specifically, this is manifested as reduced mitophagy; increased mitochondrial fission and decreased fusion; and impaired mitochondrial biogenesis.
Wenkai Fu, Junqi Wang, Nan Lu, Zhijiang Guo, Sang‐Bing Ong, Yong Gao, Hao Zhou, Xing Chang, Miao Meng   +8 more
wiley   +1 more source

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study. [PDF]

Front Immunol
Virseda-Berdices A, Requena B, Berenguer J, González-García J, Gonzalez-Riano C, Díez C, Hontañon V, Fernández-Rodríguez A, Barbas C, Resino S, Martín-Escolano R, Jiménez-Sousa MÁ.   +11 more
europepmc   +1 more source